| ENSG00000228817.3 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.043376408 |
Resistant |
| ENSG00000229348.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.018257869 |
Resistant |
| ENSG00000229776.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.04839394 |
Resistant |
| ENSG00000236204.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.041630332 |
Resistant |
| ENSG00000236467.3 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.041421714 |
Resistant |
| ENSG00000244286.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.046418305 |
Resistant |
| ENSG00000249870.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.049446209 |
Resistant |
| ENSG00000255148.2 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.039002366 |
Resistant |
| ENSG00000256609.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.041821501 |
Resistant |
| ENSG00000259201.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.022432612 |
Resistant |
| ENSG00000259682.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.01789886 |
Resistant |
| ENSG00000260641.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.006784315 |
Resistant |
| ENSG00000261773.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.038389677 |
Resistant |
| ENSG00000262810.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.049190291 |
Resistant |
| ENSG00000264222.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.045471776 |
Resistant |
| ENSG00000265787.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.039340358 |
Resistant |
| ENSG00000267112.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.040646462 |
Resistant |
| ENSG00000269720.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.041338781 |
Resistant |
| ENSG00000270164.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.02347613 |
Resistant |
| ENSG00000182165.13 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.022921899 |
Resistant |
| ENSG00000224977.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.048600412 |
Resistant |
| ENSG00000225675.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.017151907 |
Resistant |
| ENSG00000226754.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.046078456 |
Resistant |
| ENSG00000227589.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.025115432 |
Resistant |
| ENSG00000228293.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.035442032 |
Resistant |
| ENSG00000228643.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.022228753 |
Resistant |
| ENSG00000228989.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.004554685 |
Resistant |
| ENSG00000229043.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.035324258 |
Resistant |
| ENSG00000231327.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.031970921 |
Resistant |
| ENSG00000233509.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.048692098 |
Resistant |
| ENSG00000233621.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.041772272 |
Resistant |
| ENSG00000235890.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.023747352 |
Resistant |
| ENSG00000236438.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.023194178 |
Resistant |
| ENSG00000247240.3 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.017591408 |
Resistant |
| ENSG00000247828.3 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.029991388 |
Resistant |
| ENSG00000247877.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.009670105 |
Resistant |
| ENSG00000249592.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.020398098 |
Resistant |
| ENSG00000250802.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.01853653 |
Resistant |
| ENSG00000253636.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.035676481 |
Resistant |
| ENSG00000257433.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.030749793 |
Resistant |
| ENSG00000258525.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.005138212 |
Resistant |
| ENSG00000260081.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.038467586 |
Resistant |
| ENSG00000260136.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.007786716 |
Resistant |
| ENSG00000260285.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.046619032 |
Resistant |
| ENSG00000260369.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.01541547 |
Resistant |
| ENSG00000260439.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.044847564 |
Resistant |
| ENSG00000260874.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.029596783 |
Resistant |
| ENSG00000260954.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.022774814 |
Resistant |
| ENSG00000261204.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.032022509 |
Resistant |
| ENSG00000261455.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.004019205 |
Resistant |
| ENSG00000262879.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.045289953 |
Resistant |
| ENSG00000264247.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.045593621 |
Resistant |
| ENSG00000265094.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.002662273 |
Resistant |
| ENSG00000266040.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.02666643 |
Resistant |
| ENSG00000267302.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.032361441 |
Resistant |
| ENSG00000270041.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.039965152 |
Resistant |
| ENSG00000272097.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.034351476 |
Resistant |
| ENSG00000272432.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.002829276 |
Resistant |
| ENSG00000272558.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.004540609 |
Resistant |
| ENSG00000272717.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.001390129 |
Resistant |
| ENSG00000272902.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.023512696 |
Resistant |
| ENSG00000272940.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.038979348 |
Resistant |
| ENSG00000273117.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.030977666 |
Resistant |
| ENSG00000273179.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.042986056 |
Resistant |
| ENSG00000273270.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.012302983 |
Resistant |
| ENSG00000273338.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.049498819 |
Resistant |
| ENSG00000180846.4 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0040911 |
Resistant |
| ENSG00000182376.2 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023490762 |
Resistant |
| ENSG00000206176.5 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030239155 |
Resistant |
| ENSG00000224992.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030329086 |
Resistant |
| ENSG00000228201.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025436411 |
Resistant |
| ENSG00000229852.2 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024460978 |
Resistant |
| ENSG00000233885.3 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034223718 |
Resistant |
| ENSG00000234160.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019060307 |
Resistant |
| ENSG00000234665.4 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038833268 |
Resistant |
| ENSG00000234753.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010823267 |
Resistant |
| ENSG00000235159.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023935446 |
Resistant |
| ENSG00000236051.2 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003918692 |
Resistant |
| ENSG00000236352.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005336731 |
Resistant |
| ENSG00000237805.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031467193 |
Resistant |
| ENSG00000241990.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022638339 |
Resistant |
| ENSG00000244676.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011634401 |
Resistant |
| ENSG00000247240.3 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022994637 |
Resistant |
| ENSG00000248896.2 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013019634 |
Resistant |
| ENSG00000253307.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025001912 |
Resistant |
| ENSG00000256092.2 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006809117 |
Resistant |
| ENSG00000257696.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047240807 |
Resistant |
| ENSG00000258486.2 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047024262 |
Resistant |
| ENSG00000259209.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005401761 |
Resistant |
| ENSG00000259238.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038232975 |
Resistant |
| ENSG00000259623.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02827203 |
Resistant |
| ENSG00000259713.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046143458 |
Resistant |
| ENSG00000259758.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049304434 |
Resistant |
| ENSG00000259768.3 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045971037 |
Resistant |
| ENSG00000259901.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010037663 |
Resistant |
| ENSG00000260190.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042764653 |
Resistant |
| ENSG00000260447.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049987371 |
Resistant |
| ENSG00000260647.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025375694 |
Resistant |
| ENSG00000260648.2 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02646601 |
Resistant |
| ENSG00000260803.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015259877 |
Resistant |
| ENSG00000261442.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017571339 |
Resistant |
| ENSG00000261533.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023102918 |
Resistant |
| ENSG00000261663.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012010171 |
Resistant |
| ENSG00000262222.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006211667 |
Resistant |
| ENSG00000263013.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006522998 |
Resistant |
| ENSG00000263080.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041614365 |
Resistant |
| ENSG00000263350.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046875683 |
Resistant |
| ENSG00000265342.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047331739 |
Resistant |
| ENSG00000266579.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007964414 |
Resistant |
| ENSG00000267150.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046807116 |
Resistant |
| ENSG00000267161.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040472932 |
Resistant |
| ENSG00000267255.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004928109 |
Resistant |
| ENSG00000268289.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008839375 |
Resistant |
| ENSG00000270068.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03298071 |
Resistant |
| ENSG00000270137.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039251785 |
Resistant |
| ENSG00000272682.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04617402 |
Resistant |
| ENSG00000272707.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037539833 |
Resistant |
| ENSG00000273473.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009551492 |
Resistant |
| ENSG00000226115.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.042374176 |
Resistant |
| ENSG00000227375.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.00716502 |
Resistant |
| ENSG00000228084.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.00534529 |
Resistant |
| ENSG00000231794.3 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.015658302 |
Resistant |
| ENSG00000232807.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.021403856 |
Resistant |
| ENSG00000234694.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.035834777 |
Resistant |
| ENSG00000244055.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.047185652 |
Resistant |
| ENSG00000249252.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.021959139 |
Resistant |
| ENSG00000257568.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.030251995 |
Resistant |
| ENSG00000257681.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.023664983 |
Resistant |
| ENSG00000257808.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.004895737 |
Resistant |
| ENSG00000264932.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.020626647 |
Resistant |
| ENSG00000267440.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.033826685 |
Resistant |
| ENSG00000267783.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.021159868 |
Resistant |
| ENSG00000271996.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.040281491 |
Resistant |
| ENSG00000272734.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.035048266 |
Resistant |
| ENSG00000175147.7 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.04989934 |
Resistant |
| ENSG00000187156.4 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.036269705 |
Resistant |
| ENSG00000196951.6 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.03798016 |
Resistant |
| ENSG00000204044.5 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.049338449 |
Resistant |
| ENSG00000204929.7 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.038471013 |
Resistant |
| ENSG00000206195.6 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.015966346 |
Resistant |
| ENSG00000215039.2 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.036094113 |
Resistant |
| ENSG00000215394.4 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.004554081 |
Resistant |
| ENSG00000223576.2 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.001268907 |
Resistant |
| ENSG00000223734.2 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.032661942 |
Resistant |
| ENSG00000224165.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.03560844 |
Resistant |
| ENSG00000225210.5 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.008355326 |
Resistant |
| ENSG00000226330.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.037200935 |
Resistant |
| ENSG00000227906.3 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.029164992 |
Resistant |
| ENSG00000228079.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.035543316 |
Resistant |
| ENSG00000228242.3 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.027753587 |
Resistant |
| ENSG00000228294.2 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.002869295 |
Resistant |
| ENSG00000228643.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.034085872 |
Resistant |
| ENSG00000228939.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.026869635 |
Resistant |
| ENSG00000229111.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.026309429 |
Resistant |
| ENSG00000229558.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.030441859 |
Resistant |
| ENSG00000230506.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.031846487 |
Resistant |
| ENSG00000230751.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.042436274 |
Resistant |
| ENSG00000230925.3 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.043988791 |
Resistant |
| ENSG00000231691.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.044922811 |
Resistant |
| ENSG00000231709.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.019372472 |
Resistant |
| ENSG00000232300.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.038128438 |
Resistant |
| ENSG00000232354.3 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.02590406 |
Resistant |
| ENSG00000232448.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.028013048 |
Resistant |
| ENSG00000232684.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.049542426 |
Resistant |
| ENSG00000232909.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.015041073 |
Resistant |
| ENSG00000233864.3 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.030663517 |
Resistant |
| ENSG00000234215.2 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.030932055 |
Resistant |
| ENSG00000235151.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.041856444 |
Resistant |
| ENSG00000235593.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.015783321 |
Resistant |
| ENSG00000238287.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.012020699 |
Resistant |
| ENSG00000239677.2 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.022634442 |
Resistant |
| ENSG00000244306.5 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.019910824 |
Resistant |
| ENSG00000244380.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.040953518 |
Resistant |
| ENSG00000245112.2 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.009897797 |
Resistant |
| ENSG00000248240.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.045721853 |
Resistant |
| ENSG00000248664.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.047755224 |
Resistant |
| ENSG00000249234.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.025190893 |
Resistant |
| ENSG00000249635.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.0326501 |
Resistant |
| ENSG00000250366.2 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.02961257 |
Resistant |
| ENSG00000251523.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.016823681 |
Resistant |
| ENSG00000253347.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.028588212 |
Resistant |
| ENSG00000253961.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.024049828 |
Resistant |
| ENSG00000254207.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.043349972 |
Resistant |
| ENSG00000254427.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.041491456 |
Resistant |
| ENSG00000255236.2 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.022244721 |
Resistant |
| ENSG00000255410.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.030877433 |
Resistant |
| ENSG00000258731.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.045365835 |
Resistant |
| ENSG00000259453.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.020932839 |
Resistant |
| ENSG00000259774.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.026800678 |
Resistant |
| ENSG00000259953.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.041998731 |
Resistant |
| ENSG00000260176.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.040841148 |
Resistant |
| ENSG00000260269.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.033716885 |
Resistant |
| ENSG00000260619.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.008381861 |
Resistant |
| ENSG00000260947.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.040602054 |
Resistant |
| ENSG00000261019.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.041748212 |
Resistant |
| ENSG00000261141.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.013422995 |
Resistant |
| ENSG00000261288.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.024491417 |
Resistant |
| ENSG00000261600.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.048279369 |
Resistant |
| ENSG00000261613.2 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.030913478 |
Resistant |
| ENSG00000262772.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.046049193 |
Resistant |
| ENSG00000266801.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.045174965 |
Resistant |
| ENSG00000267194.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.035364828 |
Resistant |
| ENSG00000267316.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.026334672 |
Resistant |
| ENSG00000267390.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.012906586 |
Resistant |
| ENSG00000267491.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.013603341 |
Resistant |
| ENSG00000267606.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.044056556 |
Resistant |
| ENSG00000267666.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.036493829 |
Resistant |
| ENSG00000268362.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.046718319 |
Resistant |
| ENSG00000270110.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.038216405 |
Resistant |
| ENSG00000270115.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.021679257 |
Resistant |
| ENSG00000271119.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.025601797 |
Resistant |
| ENSG00000271127.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.019215082 |
Resistant |
| ENSG00000271849.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.030881908 |
Resistant |
| ENSG00000272872.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.034205234 |
Resistant |
| ENSG00000273077.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.01985343 |
Resistant |
| ENSG00000273257.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.038180244 |
Resistant |
| ENSG00000273297.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.044804695 |
Resistant |
| ENSG00000152487.6 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.020053873 |
Resistant |
| ENSG00000178803.6 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.019075742 |
Resistant |
| ENSG00000179935.5 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.029426727 |
Resistant |
| ENSG00000203288.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.040410212 |
Resistant |
| ENSG00000203496.4 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.03653989 |
Resistant |
| ENSG00000214770.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.02132747 |
Resistant |
| ENSG00000215022.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.025179347 |
Resistant |
| ENSG00000224031.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.021972117 |
Resistant |
| ENSG00000224043.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.011702233 |
Resistant |
| ENSG00000224272.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.026692602 |
Resistant |
| ENSG00000224394.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.04449858 |
Resistant |
| ENSG00000224429.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.036140556 |
Resistant |
| ENSG00000224973.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.02628019 |
Resistant |
| ENSG00000225113.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.001854071 |
Resistant |
| ENSG00000225234.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.005894471 |
Resistant |
| ENSG00000225975.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.03682507 |
Resistant |
| ENSG00000226352.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.014119999 |
Resistant |
| ENSG00000226649.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.015719921 |
Resistant |
| ENSG00000226920.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.005713844 |
Resistant |
| ENSG00000227060.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.036306269 |
Resistant |
| ENSG00000227285.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.022899978 |
Resistant |
| ENSG00000227603.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.012860733 |
Resistant |
| ENSG00000227895.4 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.014947282 |
Resistant |
| ENSG00000228153.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.027431318 |
Resistant |
| ENSG00000228395.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.011549226 |
Resistant |
| ENSG00000228794.4 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.009970496 |
Resistant |
| ENSG00000229191.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.044020571 |
Resistant |
| ENSG00000229331.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.047263524 |
Resistant |
| ENSG00000229692.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.016165918 |
Resistant |
| ENSG00000229832.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.007952094 |
Resistant |
| ENSG00000229891.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.023296061 |
Resistant |
| ENSG00000230021.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.010757146 |
Resistant |
| ENSG00000230153.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.042007636 |
Resistant |
| ENSG00000230736.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.021539599 |
Resistant |
| ENSG00000231128.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.040980545 |
Resistant |
| ENSG00000231294.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.04268551 |
Resistant |
| ENSG00000231305.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.049706933 |
Resistant |
| ENSG00000231465.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.042534487 |
Resistant |
| ENSG00000231473.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.047181403 |
Resistant |
| ENSG00000231856.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.042675269 |
Resistant |
| ENSG00000231889.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.011780148 |
Resistant |
| ENSG00000232044.4 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.039126261 |
Resistant |
| ENSG00000232057.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.037501509 |
Resistant |
| ENSG00000232455.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.031062064 |
Resistant |
| ENSG00000232593.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.035221908 |
Resistant |
| ENSG00000232611.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.040838798 |
Resistant |
| ENSG00000233056.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.012312812 |
Resistant |
| ENSG00000233183.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.048800495 |
Resistant |
| ENSG00000233806.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.04941446 |
Resistant |
| ENSG00000234019.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.040782846 |
Resistant |
| ENSG00000234062.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.019376477 |
Resistant |
| ENSG00000234156.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.029061109 |
Resistant |
| ENSG00000234661.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.035981557 |
Resistant |
| ENSG00000235189.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.048522639 |
Resistant |
| ENSG00000235461.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.049188309 |
Resistant |
| ENSG00000236244.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.04761803 |
Resistant |
| ENSG00000236358.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.022215862 |
Resistant |
| ENSG00000236423.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.040231054 |
Resistant |
| ENSG00000236558.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.04325394 |
Resistant |
| ENSG00000236869.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.018370502 |
Resistant |
| ENSG00000237336.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.009438779 |
Resistant |
| ENSG00000237481.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.022811604 |
Resistant |
| ENSG00000237937.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.041893087 |
Resistant |
| ENSG00000237940.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.025418528 |
Resistant |
| ENSG00000238197.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.044880008 |
Resistant |
| ENSG00000240401.4 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.047125684 |
Resistant |
| ENSG00000240758.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.012877374 |
Resistant |
| ENSG00000241449.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.030795241 |
Resistant |
| ENSG00000241505.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.042619892 |
Resistant |
| ENSG00000241954.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.013395731 |
Resistant |
| ENSG00000242540.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.02314056 |
Resistant |
| ENSG00000244968.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.037554433 |
Resistant |
| ENSG00000246528.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.029146973 |
Resistant |
| ENSG00000246792.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.004920487 |
Resistant |
| ENSG00000247516.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.047345226 |
Resistant |
| ENSG00000248175.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.041527869 |
Resistant |
| ENSG00000248245.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.040660048 |
Resistant |
| ENSG00000248664.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.044271925 |
Resistant |
| ENSG00000248774.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.016349057 |
Resistant |
| ENSG00000249167.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.010365523 |
Resistant |
| ENSG00000249604.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.023269854 |
Resistant |
| ENSG00000249637.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.028475627 |
Resistant |
| ENSG00000250027.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.017345677 |
Resistant |
| ENSG00000250167.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.028972446 |
Resistant |
| ENSG00000250366.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.044570272 |
Resistant |
| ENSG00000250409.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.049385822 |
Resistant |
| ENSG00000251497.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.049076593 |
Resistant |
| ENSG00000253116.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.022200737 |
Resistant |
| ENSG00000253477.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.040301108 |
Resistant |
| ENSG00000253559.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.036182915 |
Resistant |
| ENSG00000253596.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.047615783 |
Resistant |
| ENSG00000253666.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.030129924 |
Resistant |
| ENSG00000253696.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.04258158 |
Resistant |
| ENSG00000253978.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.035368268 |
Resistant |
| ENSG00000254246.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.032439222 |
Resistant |
| ENSG00000254427.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.023463091 |
Resistant |
| ENSG00000254615.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.03414844 |
Resistant |
| ENSG00000255311.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.034576446 |
Resistant |
| ENSG00000255571.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.014719777 |
Resistant |
| ENSG00000255693.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.016960221 |
Resistant |
| ENSG00000255808.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.038509559 |
Resistant |
| ENSG00000256031.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.043304662 |
Resistant |
| ENSG00000256278.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.044658783 |
Resistant |
| ENSG00000257095.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.021999919 |
Resistant |
| ENSG00000257271.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.033299159 |
Resistant |
| ENSG00000257910.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.048916676 |
Resistant |
| ENSG00000259296.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.025508766 |
Resistant |
| ENSG00000259514.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.046453786 |
Resistant |
| ENSG00000259553.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.04508975 |
Resistant |
| ENSG00000259654.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.000310483 |
Resistant |
| ENSG00000259954.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.04615136 |
Resistant |
| ENSG00000259969.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.029437227 |
Resistant |
| ENSG00000260030.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.031424127 |
Resistant |
| ENSG00000260296.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.025999911 |
Resistant |
| ENSG00000260331.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.004533965 |
Resistant |
| ENSG00000260440.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.005231353 |
Resistant |
| ENSG00000260572.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.047294349 |
Resistant |
| ENSG00000260583.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.039048005 |
Resistant |
| ENSG00000260614.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.045048297 |
Resistant |
| ENSG00000260743.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.033851376 |
Resistant |
| ENSG00000260831.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.040291104 |
Resistant |
| ENSG00000261018.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.043872876 |
Resistant |
| ENSG00000261096.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.019681026 |
Resistant |
| ENSG00000261186.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.028522707 |
Resistant |
| ENSG00000261384.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.028866729 |
Resistant |
| ENSG00000261526.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.041021937 |
Resistant |
| ENSG00000261669.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.04973345 |
Resistant |
| ENSG00000261823.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.028283904 |
Resistant |
| ENSG00000261925.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.037512165 |
Resistant |
| ENSG00000262410.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.027463557 |
Resistant |
| ENSG00000263069.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.03780562 |
Resistant |
| ENSG00000263350.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.00795088 |
Resistant |
| ENSG00000263393.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.046144259 |
Resistant |
| ENSG00000263499.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.039835026 |
Resistant |
| ENSG00000263603.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.042967667 |
Resistant |
| ENSG00000263938.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.036330986 |
Resistant |
| ENSG00000264365.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.000436758 |
Resistant |
| ENSG00000264647.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.037214199 |
Resistant |
| ENSG00000265242.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.01662534 |
Resistant |
| ENSG00000266290.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.010134945 |
Resistant |
| ENSG00000266912.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.028142823 |
Resistant |
| ENSG00000267161.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.032844847 |
Resistant |
| ENSG00000267167.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.021106937 |
Resistant |
| ENSG00000267232.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.038915224 |
Resistant |
| ENSG00000267273.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.034303707 |
Resistant |
| ENSG00000267298.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.011710422 |
Resistant |
| ENSG00000267317.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.042346305 |
Resistant |
| ENSG00000267672.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.031042384 |
Resistant |
| ENSG00000267696.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.028375129 |
Resistant |
| ENSG00000267701.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.023943315 |
Resistant |
| ENSG00000267874.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.045509918 |
Resistant |
| ENSG00000267940.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.027100513 |
Resistant |
| ENSG00000268205.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.007988319 |
Resistant |
| ENSG00000268307.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.038550404 |
Resistant |
| ENSG00000268543.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.032384583 |
Resistant |
| ENSG00000269102.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.012080369 |
Resistant |
| ENSG00000269473.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.026857758 |
Resistant |
| ENSG00000269938.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.004057044 |
Resistant |
| ENSG00000269997.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.000789789 |
Resistant |
| ENSG00000270050.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.012400659 |
Resistant |
| ENSG00000270189.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.012654251 |
Resistant |
| ENSG00000270223.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.011728804 |
Resistant |
| ENSG00000270589.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.049758185 |
Resistant |
| ENSG00000270988.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.040033901 |
Resistant |
| ENSG00000271576.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.034643935 |
Resistant |
| ENSG00000271715.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.046490076 |
Resistant |
| ENSG00000271757.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.025482073 |
Resistant |
| ENSG00000271782.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.037057566 |
Resistant |
| ENSG00000271830.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.04805568 |
Resistant |
| ENSG00000271833.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.010956114 |
Resistant |
| ENSG00000271916.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.029825103 |
Resistant |
| ENSG00000271997.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.00080213 |
Resistant |
| ENSG00000272002.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.029044812 |
Resistant |
| ENSG00000272005.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.029549053 |
Resistant |
| ENSG00000272077.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.019038874 |
Resistant |
| ENSG00000272205.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.03870319 |
Resistant |
| ENSG00000272248.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.006593762 |
Resistant |
| ENSG00000272301.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.024144112 |
Resistant |
| ENSG00000272365.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.030196242 |
Resistant |
| ENSG00000272416.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.033021455 |
Resistant |
| ENSG00000272452.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.010682466 |
Resistant |
| ENSG00000272516.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.048918609 |
Resistant |
| ENSG00000272562.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.033219308 |
Resistant |
| ENSG00000272567.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.044482941 |
Resistant |
| ENSG00000272627.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.012614506 |
Resistant |
| ENSG00000272660.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.011124956 |
Resistant |
| ENSG00000272677.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.042513698 |
Resistant |
| ENSG00000272710.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.049514234 |
Resistant |
| ENSG00000272717.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.046636679 |
Resistant |
| ENSG00000272787.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.04962268 |
Resistant |
| ENSG00000272931.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.012026783 |
Resistant |
| ENSG00000272942.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.048169087 |
Resistant |
| ENSG00000273004.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.049578954 |
Resistant |
| ENSG00000273081.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.015834108 |
Resistant |
| ENSG00000273104.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.017854675 |
Resistant |
| ENSG00000273175.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.047350091 |
Resistant |
| ENSG00000273203.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.027590178 |
Resistant |
| ENSG00000273293.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.049593162 |
Resistant |
| ENSG00000273373.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.020030634 |
Resistant |
| ENSG00000224805.2 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03891213 |
Resistant |
| ENSG00000227071.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032114068 |
Resistant |
| ENSG00000231908.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044113857 |
Resistant |
| ENSG00000233864.3 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009906441 |
Resistant |
| ENSG00000236206.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027213046 |
Resistant |
| ENSG00000238005.2 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.010209847 |
Resistant |
| ENSG00000253917.3 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045769618 |
Resistant |
| ENSG00000257279.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027528608 |
Resistant |
| ENSG00000257605.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035800068 |
Resistant |
| ENSG00000261005.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042503967 |
Resistant |
| ENSG00000266402.2 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01927451 |
Resistant |
| ENSG00000268530.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011915165 |
Resistant |
| ENSG00000271344.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015208672 |
Resistant |
| ENSG00000273142.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007171823 |
Resistant |
| ENSG00000224034.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.048938866 |
Resistant |
| ENSG00000226756.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.044739436 |
Resistant |
| ENSG00000226876.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.042717764 |
Resistant |
| ENSG00000231713.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.025111515 |
Resistant |
| ENSG00000234476.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.026689925 |
Resistant |
| ENSG00000238039.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.029265145 |
Resistant |
| ENSG00000246790.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.005502055 |
Resistant |
| ENSG00000248100.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.038754029 |
Resistant |
| ENSG00000249028.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.041161643 |
Resistant |
| ENSG00000251148.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.0380868 |
Resistant |
| ENSG00000253582.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.049406815 |
Resistant |
| ENSG00000259767.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.047932998 |
Resistant |
| ENSG00000259883.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.002073847 |
Resistant |
| ENSG00000260059.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.020747842 |
Resistant |
| ENSG00000261523.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.022708295 |
Resistant |
| ENSG00000264785.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.029496091 |
Resistant |
| ENSG00000266654.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.042807603 |
Resistant |
| ENSG00000269923.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.031368329 |
Resistant |
| ENSG00000272328.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.036047033 |
Resistant |
| ENSG00000183242.7 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.020447663 |
Resistant |
| ENSG00000184274.3 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.00785354 |
Resistant |
| ENSG00000184324.11 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.021895638 |
Resistant |
| ENSG00000197463.8 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.021063598 |
Resistant |
| ENSG00000204362.5 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.038343655 |
Resistant |
| ENSG00000204625.6 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.048216031 |
Resistant |
| ENSG00000213963.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.017064936 |
Resistant |
| ENSG00000214803.3 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.009679655 |
Resistant |
| ENSG00000216863.5 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.001928581 |
Resistant |
| ENSG00000223779.4 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.006247478 |
Resistant |
| ENSG00000223834.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.035870726 |
Resistant |
| ENSG00000223842.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.023876438 |
Resistant |
| ENSG00000224116.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.001651378 |
Resistant |
| ENSG00000224698.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.031499622 |
Resistant |
| ENSG00000225087.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.040722296 |
Resistant |
| ENSG00000226263.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.010532047 |
Resistant |
| ENSG00000226445.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.026351968 |
Resistant |
| ENSG00000226453.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.009493802 |
Resistant |
| ENSG00000226803.3 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.024085446 |
Resistant |
| ENSG00000227214.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.016538647 |
Resistant |
| ENSG00000227279.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.037652273 |
Resistant |
| ENSG00000227895.4 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.017993281 |
Resistant |
| ENSG00000228251.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.007615695 |
Resistant |
| ENSG00000228404.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.008113213 |
Resistant |
| ENSG00000228496.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.005151324 |
Resistant |
| ENSG00000229267.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.040975592 |
Resistant |
| ENSG00000229404.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.001926845 |
Resistant |
| ENSG00000229931.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.022098724 |
Resistant |
| ENSG00000230021.3 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.0436796 |
Resistant |
| ENSG00000230773.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.002797596 |
Resistant |
| ENSG00000230876.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.021211897 |
Resistant |
| ENSG00000230880.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.033829969 |
Resistant |
| ENSG00000231106.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.022199301 |
Resistant |
| ENSG00000231505.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.027171698 |
Resistant |
| ENSG00000231595.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.046279347 |
Resistant |
| ENSG00000231646.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.001039261 |
Resistant |
| ENSG00000231971.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.023059208 |
Resistant |
| ENSG00000231999.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.013739798 |
Resistant |
| ENSG00000232324.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.016210221 |
Resistant |
| ENSG00000232406.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.026548644 |
Resistant |
| ENSG00000232876.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.012627553 |
Resistant |
| ENSG00000233430.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.046634781 |
Resistant |
| ENSG00000233496.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.0000501 |
Resistant |
| ENSG00000233547.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.015356653 |
Resistant |
| ENSG00000233621.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.027533929 |
Resistant |
| ENSG00000234584.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.025334979 |
Resistant |
| ENSG00000234694.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.002548618 |
Resistant |
| ENSG00000234948.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.029748985 |
Resistant |
| ENSG00000235590.3 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.027383855 |
Resistant |
| ENSG00000236799.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.005809948 |
Resistant |
| ENSG00000237021.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.026726254 |
Resistant |
| ENSG00000237361.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.033013543 |
Resistant |
| ENSG00000237525.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.039979341 |
Resistant |
| ENSG00000239335.4 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.011212586 |
Resistant |
| ENSG00000239462.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.018401484 |
Resistant |
| ENSG00000240005.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.000736971 |
Resistant |
| ENSG00000240050.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.018039253 |
Resistant |
| ENSG00000240476.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.012995622 |
Resistant |
| ENSG00000241219.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.007863453 |
Resistant |
| ENSG00000243849.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.004107366 |
Resistant |
| ENSG00000244349.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.023877972 |
Resistant |
| ENSG00000245060.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.006069283 |
Resistant |
| ENSG00000245281.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.007401445 |
Resistant |
| ENSG00000245651.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.016386221 |
Resistant |
| ENSG00000246067.3 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.001015141 |
Resistant |
| ENSG00000247137.4 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.013845385 |
Resistant |
| ENSG00000249378.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.004173422 |
Resistant |
| ENSG00000249379.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.009995065 |
Resistant |
| ENSG00000250192.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.00103129 |
Resistant |
| ENSG00000251144.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.041845574 |
Resistant |
| ENSG00000251164.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.035120186 |
Resistant |
| ENSG00000251666.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.018862156 |
Resistant |
| ENSG00000253552.3 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.003492587 |
Resistant |
| ENSG00000253875.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.003549087 |
Resistant |
| ENSG00000253947.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.015277791 |
Resistant |
| ENSG00000254267.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.031085362 |
Resistant |
| ENSG00000254691.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.016051755 |
Resistant |
| ENSG00000255082.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.005870751 |
Resistant |
| ENSG00000255503.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.002023028 |
Resistant |
| ENSG00000255968.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.006865914 |
Resistant |
| ENSG00000256234.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.028173169 |
Resistant |
| ENSG00000257636.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.034829109 |
Resistant |
| ENSG00000258017.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.048474498 |
Resistant |
| ENSG00000258181.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.048782022 |
Resistant |
| ENSG00000258458.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.04757072 |
Resistant |
| ENSG00000258693.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.031851059 |
Resistant |
| ENSG00000258754.3 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.008962352 |
Resistant |
| ENSG00000258821.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.041662798 |
Resistant |
| ENSG00000259065.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.002038389 |
Resistant |
| ENSG00000259158.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.00118745 |
Resistant |
| ENSG00000259376.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.047252409 |
Resistant |
| ENSG00000259640.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.041868306 |
Resistant |
| ENSG00000259736.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.000000211 |
Resistant |
| ENSG00000259834.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.008969207 |
Resistant |
| ENSG00000259863.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.012908321 |
Resistant |
| ENSG00000259967.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.039361704 |
Resistant |
| ENSG00000259986.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.045343811 |
Resistant |
| ENSG00000260141.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.005655743 |
Resistant |
| ENSG00000260167.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.012279434 |
Resistant |
| ENSG00000260281.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.039109128 |
Resistant |
| ENSG00000260579.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.031150225 |
Resistant |
| ENSG00000260664.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.001254957 |
Resistant |
| ENSG00000260841.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.018712184 |
Resistant |
| ENSG00000260910.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.001897867 |
Resistant |
| ENSG00000261122.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.007434379 |
Resistant |
| ENSG00000261431.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.019713106 |
Resistant |
| ENSG00000261610.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.033778613 |
Resistant |
| ENSG00000262172.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.008145107 |
Resistant |
| ENSG00000262319.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.001024454 |
Resistant |
| ENSG00000262362.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.023069346 |
Resistant |
| ENSG00000263412.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.001057829 |
Resistant |
| ENSG00000265728.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.000859874 |
Resistant |
| ENSG00000267009.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.002302484 |
Resistant |
| ENSG00000267255.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.042817517 |
Resistant |
| ENSG00000267416.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.005505863 |
Resistant |
| ENSG00000267498.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.03175501 |
Resistant |
| ENSG00000267644.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.044167103 |
Resistant |
| ENSG00000269038.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.001806829 |
Resistant |
| ENSG00000270049.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.002823934 |
Resistant |
| ENSG00000271382.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.000255498 |
Resistant |
| ENSG00000271752.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.000884886 |
Resistant |
| ENSG00000271821.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.015771357 |
Resistant |
| ENSG00000271857.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.001474268 |
Resistant |
| ENSG00000272023.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.03079437 |
Resistant |
| ENSG00000272183.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.000749697 |
Resistant |
| ENSG00000272389.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.000924257 |
Resistant |
| ENSG00000272529.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.009581057 |
Resistant |
| ENSG00000272692.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.001582007 |
Resistant |
| ENSG00000272827.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.022417046 |
Resistant |
| ENSG00000272966.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.015337926 |
Resistant |
| ENSG00000273129.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.003410824 |
Resistant |
| ENSG00000273237.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.000472918 |
Resistant |
| ENSG00000273374.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.015461269 |
Resistant |
| ENSG00000206567.5 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.020871186 |
Resistant |
| ENSG00000223390.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.043332995 |
Resistant |
| ENSG00000223812.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.022512772 |
Resistant |
| ENSG00000224844.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.035338083 |
Resistant |
| ENSG00000226380.3 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.00458122 |
Resistant |
| ENSG00000226812.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.031720499 |
Resistant |
| ENSG00000227588.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.019051277 |
Resistant |
| ENSG00000228010.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.01048608 |
Resistant |
| ENSG00000229697.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.012821592 |
Resistant |
| ENSG00000230310.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.026157852 |
Resistant |
| ENSG00000230937.5 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.049643231 |
Resistant |
| ENSG00000232504.4 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.011766698 |
Resistant |
| ENSG00000233244.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.023317903 |
Resistant |
| ENSG00000234477.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.002943607 |
Resistant |
| ENSG00000237520.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.013273242 |
Resistant |
| ENSG00000237705.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.016536718 |
Resistant |
| ENSG00000238005.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.022541676 |
Resistant |
| ENSG00000241220.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.016462552 |
Resistant |
| ENSG00000250404.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.008875002 |
Resistant |
| ENSG00000253641.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.044773061 |
Resistant |
| ENSG00000254739.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.048821619 |
Resistant |
| ENSG00000255089.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.025425047 |
Resistant |
| ENSG00000255310.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.007207222 |
Resistant |
| ENSG00000259635.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.007286093 |
Resistant |
| ENSG00000261291.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.027537447 |
Resistant |
| ENSG00000263567.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.034130011 |
Resistant |
| ENSG00000264188.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.039685011 |
Resistant |
| ENSG00000266904.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.04743389 |
Resistant |
| ENSG00000266912.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.01473785 |
Resistant |
| ENSG00000266976.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.034300493 |
Resistant |
| ENSG00000268613.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.021019034 |
Resistant |
| ENSG00000269873.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.026435579 |
Resistant |
| ENSG00000269918.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.043891844 |
Resistant |
| ENSG00000270066.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.026979455 |
Resistant |
| ENSG00000270116.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.046860419 |
Resistant |
| ENSG00000273084.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.005777608 |
Resistant |
| ENSG00000224885.1 |
Doxorubicin (Adriamycin) |
Bladder urothelial carcinoma |
0.039803191 |
Sensitive |
| ENSG00000236064.1 |
Doxorubicin (Adriamycin) |
Bladder urothelial carcinoma |
0.037556417 |
Sensitive |
| ENSG00000236842.1 |
Doxorubicin (Adriamycin) |
Bladder urothelial carcinoma |
0.019716734 |
Sensitive |
| ENSG00000254144.2 |
Doxorubicin (Adriamycin) |
Bladder urothelial carcinoma |
0.017100019 |
Sensitive |
| ENSG00000254718.2 |
Doxorubicin (Adriamycin) |
Bladder urothelial carcinoma |
0.023953881 |
Sensitive |
| ENSG00000254859.1 |
Doxorubicin (Adriamycin) |
Bladder urothelial carcinoma |
0.022797814 |
Sensitive |
| ENSG00000265185.2 |
Doxorubicin (Adriamycin) |
Bladder urothelial carcinoma |
0.028515166 |
Sensitive |
| ENSG00000273073.1 |
Doxorubicin (Adriamycin) |
Bladder urothelial carcinoma |
0.016689179 |
Sensitive |
| ENSG00000175773.8 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.015719201 |
Sensitive |
| ENSG00000204860.4 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.010158489 |
Sensitive |
| ENSG00000223393.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.021666833 |
Sensitive |
| ENSG00000223714.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.03392514 |
Sensitive |
| ENSG00000223935.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.018119134 |
Sensitive |
| ENSG00000224269.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.004497238 |
Sensitive |
| ENSG00000224652.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.028769373 |
Sensitive |
| ENSG00000224843.2 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.033987982 |
Sensitive |
| ENSG00000225518.2 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.039030286 |
Sensitive |
| ENSG00000225889.3 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.040661284 |
Sensitive |
| ENSG00000225956.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.042655573 |
Sensitive |
| ENSG00000226377.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.042458469 |
Sensitive |
| ENSG00000226465.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.040481297 |
Sensitive |
| ENSG00000226578.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.023976763 |
Sensitive |
| ENSG00000226609.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.037343042 |
Sensitive |
| ENSG00000226816.2 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.045122988 |
Sensitive |
| ENSG00000227704.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.038662411 |
Sensitive |
| ENSG00000228065.6 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.009638116 |
Sensitive |
| ENSG00000228115.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.041848744 |
Sensitive |
| ENSG00000228630.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.020989272 |
Sensitive |
| ENSG00000228792.2 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.036735694 |
Sensitive |
| ENSG00000230010.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.022119484 |
Sensitive |
| ENSG00000230090.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.040217273 |
Sensitive |
| ENSG00000231107.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.031030264 |
Sensitive |
| ENSG00000231134.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.025242082 |
Sensitive |
| ENSG00000231851.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.042914845 |
Sensitive |
| ENSG00000232028.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.030109197 |
Sensitive |
| ENSG00000232445.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.024284453 |
Sensitive |
| ENSG00000233547.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.018836429 |
Sensitive |
| ENSG00000233930.3 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.047881174 |
Sensitive |
| ENSG00000234690.2 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.03235543 |
Sensitive |
| ENSG00000235257.4 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.04089461 |
Sensitive |
| ENSG00000235499.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.042264331 |
Sensitive |
| ENSG00000235823.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.026112348 |
Sensitive |
| ENSG00000236780.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.042099597 |
Sensitive |
| ENSG00000237234.2 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.03099798 |
Sensitive |
| ENSG00000237899.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.012443533 |
Sensitive |
| ENSG00000237943.2 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.042838316 |
Sensitive |
| ENSG00000240086.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.033552443 |
Sensitive |
| ENSG00000244676.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.047672876 |
Sensitive |
| ENSG00000246263.2 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.020443834 |
Sensitive |
| ENSG00000247131.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.015098051 |
Sensitive |
| ENSG00000250260.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.013142402 |
Sensitive |
| ENSG00000253666.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.037821882 |
Sensitive |
| ENSG00000255145.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.031413706 |
Sensitive |
| ENSG00000255234.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.047065852 |
Sensitive |
| ENSG00000255236.2 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.031396448 |
Sensitive |
| ENSG00000258561.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.018505705 |
Sensitive |
| ENSG00000259439.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.033601379 |
Sensitive |
| ENSG00000260022.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.042579201 |
Sensitive |
| ENSG00000260920.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.008994716 |
Sensitive |
| ENSG00000261521.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.030254449 |
Sensitive |
| ENSG00000261798.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.005124925 |
Sensitive |
| ENSG00000262410.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.04588023 |
Sensitive |
| ENSG00000262951.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.045166955 |
Sensitive |
| ENSG00000263766.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.012019275 |
Sensitive |
| ENSG00000267272.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.04289697 |
Sensitive |
| ENSG00000267374.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.008297664 |
Sensitive |
| ENSG00000267729.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.047113263 |
Sensitive |
| ENSG00000268842.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.048788451 |
Sensitive |
| ENSG00000270246.2 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.041980626 |
Sensitive |
| ENSG00000271133.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.028929839 |
Sensitive |
| ENSG00000271659.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.049604827 |
Sensitive |
| ENSG00000272465.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.019762809 |
Sensitive |
| ENSG00000272904.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.009837267 |
Sensitive |
| ENSG00000273004.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.031524633 |
Sensitive |
| ENSG00000273056.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.026728918 |
Sensitive |
| ENSG00000273097.1 |
Doxorubicin (Adriamycin) |
Breast invasive carcinoma |
0.039620266 |
Sensitive |
| ENSG00000180846.4 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.042972201 |
Sensitive |
| ENSG00000185186.4 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.040411254 |
Sensitive |
| ENSG00000203307.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.049568816 |
Sensitive |
| ENSG00000205890.3 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.044477575 |
Sensitive |
| ENSG00000225037.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.028185059 |
Sensitive |
| ENSG00000225075.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.037554391 |
Sensitive |
| ENSG00000225177.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.004465235 |
Sensitive |
| ENSG00000226091.3 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.029523379 |
Sensitive |
| ENSG00000226380.3 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.004410925 |
Sensitive |
| ENSG00000227740.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.027771845 |
Sensitive |
| ENSG00000228353.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.005389496 |
Sensitive |
| ENSG00000229227.4 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.042177629 |
Sensitive |
| ENSG00000229656.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.027428236 |
Sensitive |
| ENSG00000230590.3 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.03903379 |
Sensitive |
| ENSG00000230850.3 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.032113026 |
Sensitive |
| ENSG00000231329.3 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.034646188 |
Sensitive |
| ENSG00000231840.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.035220002 |
Sensitive |
| ENSG00000231944.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.049491219 |
Sensitive |
| ENSG00000232406.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.045109595 |
Sensitive |
| ENSG00000235908.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.035776961 |
Sensitive |
| ENSG00000236393.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.034780317 |
Sensitive |
| ENSG00000236540.3 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.027234904 |
Sensitive |
| ENSG00000238279.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.021328015 |
Sensitive |
| ENSG00000247363.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.029375569 |
Sensitive |
| ENSG00000250659.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.039894761 |
Sensitive |
| ENSG00000251143.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.047069294 |
Sensitive |
| ENSG00000254554.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.042928802 |
Sensitive |
| ENSG00000255449.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.047117623 |
Sensitive |
| ENSG00000255717.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.007479523 |
Sensitive |
| ENSG00000255741.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.048221827 |
Sensitive |
| ENSG00000258077.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.020308678 |
Sensitive |
| ENSG00000258136.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.03186129 |
Sensitive |
| ENSG00000258825.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.023808231 |
Sensitive |
| ENSG00000258904.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.046119844 |
Sensitive |
| ENSG00000259416.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.028907909 |
Sensitive |
| ENSG00000260141.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.038642128 |
Sensitive |
| ENSG00000261094.2 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.020724937 |
Sensitive |
| ENSG00000261770.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.003294408 |
Sensitive |
| ENSG00000267096.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.0300099 |
Sensitive |
| ENSG00000267197.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.038985179 |
Sensitive |
| ENSG00000267263.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.021043827 |
Sensitive |
| ENSG00000267265.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.040527682 |
Sensitive |
| ENSG00000267375.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.040049183 |
Sensitive |
| ENSG00000268205.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.015738293 |
Sensitive |
| ENSG00000269161.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.018833805 |
Sensitive |
| ENSG00000271912.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.039858349 |
Sensitive |
| ENSG00000272630.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.040136906 |
Sensitive |
| ENSG00000272734.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.032372591 |
Sensitive |
| ENSG00000273009.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.0183167 |
Sensitive |
| ENSG00000273188.1 |
Doxorubicin (Adriamycin) |
Colon adenocarcinoma |
0.043998053 |
Sensitive |
| ENSG00000230552.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047916208 |
Sensitive |
| ENSG00000231290.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011294536 |
Sensitive |
| ENSG00000250786.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004743708 |
Sensitive |
| ENSG00000272141.1 |
Doxorubicin (Adriamycin) |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010582346 |
Sensitive |
| ENSG00000100181.17 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.016171143 |
Sensitive |
| ENSG00000131484.3 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.037960156 |
Sensitive |
| ENSG00000179743.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.005524469 |
Sensitive |
| ENSG00000184068.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.014897625 |
Sensitive |
| ENSG00000204044.5 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.044390509 |
Sensitive |
| ENSG00000204758.3 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.041567793 |
Sensitive |
| ENSG00000211683.3 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.017705888 |
Sensitive |
| ENSG00000213468.3 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.007520854 |
Sensitive |
| ENSG00000213971.3 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.038870044 |
Sensitive |
| ENSG00000214347.5 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.0045506 |
Sensitive |
| ENSG00000223571.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.023276051 |
Sensitive |
| ENSG00000224020.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.017447506 |
Sensitive |
| ENSG00000225032.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.003007706 |
Sensitive |
| ENSG00000225218.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.043050186 |
Sensitive |
| ENSG00000225767.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.02933376 |
Sensitive |
| ENSG00000225778.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.038755641 |
Sensitive |
| ENSG00000226245.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.046833882 |
Sensitive |
| ENSG00000226386.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.041654618 |
Sensitive |
| ENSG00000226889.3 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.04076998 |
Sensitive |
| ENSG00000226950.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.018603703 |
Sensitive |
| ENSG00000228323.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.019358193 |
Sensitive |
| ENSG00000229111.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.018500562 |
Sensitive |
| ENSG00000231393.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.026767582 |
Sensitive |
| ENSG00000231927.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.018576307 |
Sensitive |
| ENSG00000232656.3 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.001126045 |
Sensitive |
| ENSG00000232876.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.004749727 |
Sensitive |
| ENSG00000232931.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.049618849 |
Sensitive |
| ENSG00000233296.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.04455266 |
Sensitive |
| ENSG00000235802.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.01212534 |
Sensitive |
| ENSG00000236308.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.021926741 |
Sensitive |
| ENSG00000237328.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.018681102 |
Sensitive |
| ENSG00000237689.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.022626338 |
Sensitive |
| ENSG00000237805.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.039370939 |
Sensitive |
| ENSG00000237934.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.044339268 |
Sensitive |
| ENSG00000237945.3 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.025587733 |
Sensitive |
| ENSG00000237976.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.042467775 |
Sensitive |
| ENSG00000241666.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.035457615 |
Sensitive |
| ENSG00000244203.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.040575351 |
Sensitive |
| ENSG00000245059.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.033768209 |
Sensitive |
| ENSG00000248668.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.008524541 |
Sensitive |
| ENSG00000248758.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.036478812 |
Sensitive |
| ENSG00000248968.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.001880322 |
Sensitive |
| ENSG00000249487.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.041735981 |
Sensitive |
| ENSG00000249684.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.018955611 |
Sensitive |
| ENSG00000251323.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.026071221 |
Sensitive |
| ENSG00000253374.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.001399546 |
Sensitive |
| ENSG00000253708.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.028189188 |
Sensitive |
| ENSG00000253859.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.001307506 |
Sensitive |
| ENSG00000253893.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.015869418 |
Sensitive |
| ENSG00000254592.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.009756974 |
Sensitive |
| ENSG00000254691.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.002553064 |
Sensitive |
| ENSG00000255052.3 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.03041698 |
Sensitive |
| ENSG00000255741.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.047280168 |
Sensitive |
| ENSG00000257151.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.036797347 |
Sensitive |
| ENSG00000258454.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.036179915 |
Sensitive |
| ENSG00000259055.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.042612748 |
Sensitive |
| ENSG00000259135.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.028816844 |
Sensitive |
| ENSG00000259250.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.042907933 |
Sensitive |
| ENSG00000259804.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.035419125 |
Sensitive |
| ENSG00000259894.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.048443937 |
Sensitive |
| ENSG00000260017.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.028458316 |
Sensitive |
| ENSG00000260022.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.039943326 |
Sensitive |
| ENSG00000260156.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.01226487 |
Sensitive |
| ENSG00000260278.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.033661725 |
Sensitive |
| ENSG00000260296.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.020729002 |
Sensitive |
| ENSG00000260423.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.021241693 |
Sensitive |
| ENSG00000260973.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.017543635 |
Sensitive |
| ENSG00000260986.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.009026802 |
Sensitive |
| ENSG00000261003.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.045520381 |
Sensitive |
| ENSG00000261318.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.038925707 |
Sensitive |
| ENSG00000261428.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.012763787 |
Sensitive |
| ENSG00000261476.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.006379568 |
Sensitive |
| ENSG00000261839.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.025602731 |
Sensitive |
| ENSG00000261886.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.003690063 |
Sensitive |
| ENSG00000263657.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.023673949 |
Sensitive |
| ENSG00000266236.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.034357675 |
Sensitive |
| ENSG00000266677.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.027455395 |
Sensitive |
| ENSG00000266969.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.040697315 |
Sensitive |
| ENSG00000267053.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.018826674 |
Sensitive |
| ENSG00000267150.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.006790118 |
Sensitive |
| ENSG00000267161.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.047301602 |
Sensitive |
| ENSG00000267321.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.029309479 |
Sensitive |
| ENSG00000267551.3 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.033964857 |
Sensitive |
| ENSG00000267568.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.024526856 |
Sensitive |
| ENSG00000267605.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.037843984 |
Sensitive |
| ENSG00000267655.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.03661303 |
Sensitive |
| ENSG00000268340.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.047060691 |
Sensitive |
| ENSG00000268945.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.034419387 |
Sensitive |
| ENSG00000269194.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.013918832 |
Sensitive |
| ENSG00000269951.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.004497278 |
Sensitive |
| ENSG00000270048.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.047074412 |
Sensitive |
| ENSG00000270074.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.020261998 |
Sensitive |
| ENSG00000270109.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.039494845 |
Sensitive |
| ENSG00000270117.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.038240805 |
Sensitive |
| ENSG00000270159.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.023260296 |
Sensitive |
| ENSG00000270237.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.009006169 |
Sensitive |
| ENSG00000270482.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.022203235 |
Sensitive |
| ENSG00000270828.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.031310064 |
Sensitive |
| ENSG00000271367.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.028119112 |
Sensitive |
| ENSG00000271717.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.02431144 |
Sensitive |
| ENSG00000271869.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.011547543 |
Sensitive |
| ENSG00000271948.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.009049823 |
Sensitive |
| ENSG00000271966.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.045902937 |
Sensitive |
| ENSG00000272023.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.023751954 |
Sensitive |
| ENSG00000272221.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.028294829 |
Sensitive |
| ENSG00000272301.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.018370536 |
Sensitive |
| ENSG00000272373.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.019785192 |
Sensitive |
| ENSG00000272374.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.046092982 |
Sensitive |
| ENSG00000272426.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.029276157 |
Sensitive |
| ENSG00000272452.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.032253598 |
Sensitive |
| ENSG00000272462.2 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.020571714 |
Sensitive |
| ENSG00000272463.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.037761624 |
Sensitive |
| ENSG00000272524.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.007346649 |
Sensitive |
| ENSG00000272525.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.023881271 |
Sensitive |
| ENSG00000272556.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.042146855 |
Sensitive |
| ENSG00000272754.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.037933877 |
Sensitive |
| ENSG00000272777.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.007500777 |
Sensitive |
| ENSG00000272795.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.014754706 |
Sensitive |
| ENSG00000272810.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.011402608 |
Sensitive |
| ENSG00000272995.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.031171162 |
Sensitive |
| ENSG00000273001.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.041682909 |
Sensitive |
| ENSG00000273073.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.043853183 |
Sensitive |
| ENSG00000273091.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.009342291 |
Sensitive |
| ENSG00000273156.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.03234775 |
Sensitive |
| ENSG00000273428.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.029649964 |
Sensitive |
| ENSG00000273447.1 |
Doxorubicin (Adriamycin) |
Chronic Lymphocytic Leukemia |
0.027110052 |
Sensitive |
| ENSG00000197989.9 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.046783003 |
Sensitive |
| ENSG00000206176.5 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.042804168 |
Sensitive |
| ENSG00000223528.3 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.038349354 |
Sensitive |
| ENSG00000225177.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.000545528 |
Sensitive |
| ENSG00000226367.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.022889095 |
Sensitive |
| ENSG00000226883.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.003530502 |
Sensitive |
| ENSG00000227646.3 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.049243196 |
Sensitive |
| ENSG00000228470.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.006730196 |
Sensitive |
| ENSG00000229996.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.031011757 |
Sensitive |
| ENSG00000235848.2 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.041619778 |
Sensitive |
| ENSG00000236199.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.040314261 |
Sensitive |
| ENSG00000236651.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.030461512 |
Sensitive |
| ENSG00000237424.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.009364683 |
Sensitive |
| ENSG00000237768.2 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.0451425 |
Sensitive |
| ENSG00000237943.2 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.023023444 |
Sensitive |
| ENSG00000242290.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.025906541 |
Sensitive |
| ENSG00000244260.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.017783034 |
Sensitive |
| ENSG00000249898.3 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.009458302 |
Sensitive |
| ENSG00000250635.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.015733324 |
Sensitive |
| ENSG00000253302.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.044884182 |
Sensitive |
| ENSG00000257285.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.010958709 |
Sensitive |
| ENSG00000258777.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.019237627 |
Sensitive |
| ENSG00000268516.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.025237181 |
Sensitive |
| ENSG00000269680.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.04617369 |
Sensitive |
| ENSG00000270168.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.028638497 |
Sensitive |
| ENSG00000272320.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.010762918 |
Sensitive |
| ENSG00000272782.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.008961726 |
Sensitive |
| ENSG00000273165.1 |
Doxorubicin (Adriamycin) |
Brain lower grade glioma |
0.040265077 |
Sensitive |
| ENSG00000146666.4 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.011970804 |
Sensitive |
| ENSG00000177406.4 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.027007707 |
Sensitive |
| ENSG00000182021.5 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.011450474 |
Sensitive |
| ENSG00000182648.7 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.009624236 |
Sensitive |
| ENSG00000184274.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.024615489 |
Sensitive |
| ENSG00000186594.8 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.006393247 |
Sensitive |
| ENSG00000204362.5 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.021460282 |
Sensitive |
| ENSG00000204792.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.038028721 |
Sensitive |
| ENSG00000215863.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.007552413 |
Sensitive |
| ENSG00000223477.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.032414345 |
Sensitive |
| ENSG00000223759.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.001905481 |
Sensitive |
| ENSG00000223774.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.040533065 |
Sensitive |
| ENSG00000223779.4 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.017362778 |
Sensitive |
| ENSG00000224081.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.036098954 |
Sensitive |
| ENSG00000224733.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.039507598 |
Sensitive |
| ENSG00000225269.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.020284437 |
Sensitive |
| ENSG00000225311.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.015705048 |
Sensitive |
| ENSG00000225541.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.0293762 |
Sensitive |
| ENSG00000225684.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.003110911 |
Sensitive |
| ENSG00000226026.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.013433654 |
Sensitive |
| ENSG00000226067.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.002956618 |
Sensitive |
| ENSG00000226637.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.008552832 |
Sensitive |
| ENSG00000226800.5 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.048460684 |
Sensitive |
| ENSG00000227308.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.023542257 |
Sensitive |
| ENSG00000227375.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.009879389 |
Sensitive |
| ENSG00000227496.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.046084514 |
Sensitive |
| ENSG00000227591.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.009469248 |
Sensitive |
| ENSG00000227634.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.029800292 |
Sensitive |
| ENSG00000227678.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.034810977 |
Sensitive |
| ENSG00000227925.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.035626452 |
Sensitive |
| ENSG00000228649.4 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.016897551 |
Sensitive |
| ENSG00000229160.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.002929143 |
Sensitive |
| ENSG00000229931.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.044568677 |
Sensitive |
| ENSG00000229964.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.049724247 |
Sensitive |
| ENSG00000229989.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.016534528 |
Sensitive |
| ENSG00000230479.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.011425656 |
Sensitive |
| ENSG00000230550.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.005505578 |
Sensitive |
| ENSG00000230615.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.028878072 |
Sensitive |
| ENSG00000230695.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.03433526 |
Sensitive |
| ENSG00000230857.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.048739448 |
Sensitive |
| ENSG00000230940.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.01660864 |
Sensitive |
| ENSG00000231298.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.014981305 |
Sensitive |
| ENSG00000231528.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.002533871 |
Sensitive |
| ENSG00000231551.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.025855025 |
Sensitive |
| ENSG00000231646.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.044305393 |
Sensitive |
| ENSG00000231734.4 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.008276113 |
Sensitive |
| ENSG00000232194.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.019819492 |
Sensitive |
| ENSG00000232386.5 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.02030696 |
Sensitive |
| ENSG00000232533.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.044397266 |
Sensitive |
| ENSG00000232642.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.04583581 |
Sensitive |
| ENSG00000232759.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.026329601 |
Sensitive |
| ENSG00000232891.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.042343981 |
Sensitive |
| ENSG00000232949.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.010346679 |
Sensitive |
| ENSG00000233430.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.018454633 |
Sensitive |
| ENSG00000233532.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.038931237 |
Sensitive |
| ENSG00000233776.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.014270134 |
Sensitive |
| ENSG00000233818.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.007324759 |
Sensitive |
| ENSG00000234155.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.043700258 |
Sensitive |
| ENSG00000234199.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.001507974 |
Sensitive |
| ENSG00000234380.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.031613595 |
Sensitive |
| ENSG00000234902.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.041832375 |
Sensitive |
| ENSG00000235398.4 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.014229493 |
Sensitive |
| ENSG00000235427.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.031059142 |
Sensitive |
| ENSG00000235724.4 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.023866281 |
Sensitive |
| ENSG00000235781.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.005576486 |
Sensitive |
| ENSG00000235848.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.049477747 |
Sensitive |
| ENSG00000235884.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.018897749 |
Sensitive |
| ENSG00000235999.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.001101289 |
Sensitive |
| ENSG00000236204.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.018673915 |
Sensitive |
| ENSG00000236383.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.018095591 |
Sensitive |
| ENSG00000236740.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.032486643 |
Sensitive |
| ENSG00000236751.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.01746908 |
Sensitive |
| ENSG00000236914.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.001772596 |
Sensitive |
| ENSG00000236936.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.035695082 |
Sensitive |
| ENSG00000236943.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.022210941 |
Sensitive |
| ENSG00000237476.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.025719844 |
Sensitive |
| ENSG00000237505.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.024204657 |
Sensitive |
| ENSG00000237595.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.032843188 |
Sensitive |
| ENSG00000237685.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.044453662 |
Sensitive |
| ENSG00000237803.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.017664122 |
Sensitive |
| ENSG00000238042.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.020774192 |
Sensitive |
| ENSG00000238160.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.016864935 |
Sensitive |
| ENSG00000238290.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.018385963 |
Sensitive |
| ENSG00000239498.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.006374006 |
Sensitive |
| ENSG00000239641.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.02012763 |
Sensitive |
| ENSG00000240541.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.036411351 |
Sensitive |
| ENSG00000240922.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.04949199 |
Sensitive |
| ENSG00000241985.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.01021948 |
Sensitive |
| ENSG00000243350.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.046617417 |
Sensitive |
| ENSG00000243797.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.040252163 |
Sensitive |
| ENSG00000244198.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.001006846 |
Sensitive |
| ENSG00000244459.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.009841662 |
Sensitive |
| ENSG00000244479.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.007886082 |
Sensitive |
| ENSG00000245311.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.028879395 |
Sensitive |
| ENSG00000246582.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.022563984 |
Sensitive |
| ENSG00000247925.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.017291139 |
Sensitive |
| ENSG00000248100.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.049966073 |
Sensitive |
| ENSG00000248125.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.027565324 |
Sensitive |
| ENSG00000248388.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.020311944 |
Sensitive |
| ENSG00000248571.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.003012014 |
Sensitive |
| ENSG00000248996.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.000816418 |
Sensitive |
| ENSG00000249207.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.028882116 |
Sensitive |
| ENSG00000249295.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.015705623 |
Sensitive |
| ENSG00000249685.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.007050197 |
Sensitive |
| ENSG00000249740.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.026807119 |
Sensitive |
| ENSG00000249942.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.041067646 |
Sensitive |
| ENSG00000250041.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.014781419 |
Sensitive |
| ENSG00000250049.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.01615649 |
Sensitive |
| ENSG00000250159.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.00402687 |
Sensitive |
| ENSG00000250286.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.019975901 |
Sensitive |
| ENSG00000250451.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.044580025 |
Sensitive |
| ENSG00000250511.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.047695193 |
Sensitive |
| ENSG00000250548.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.012586688 |
Sensitive |
| ENSG00000250551.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.042868321 |
Sensitive |
| ENSG00000250602.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.009727356 |
Sensitive |
| ENSG00000250608.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.00913408 |
Sensitive |
| ENSG00000250659.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.01879011 |
Sensitive |
| ENSG00000250714.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.028301144 |
Sensitive |
| ENSG00000251136.4 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.000852438 |
Sensitive |
| ENSG00000251314.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.037061667 |
Sensitive |
| ENSG00000251379.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.044974297 |
Sensitive |
| ENSG00000253111.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.023507113 |
Sensitive |
| ENSG00000253210.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.031885234 |
Sensitive |
| ENSG00000253311.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.044299495 |
Sensitive |
| ENSG00000253526.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.019485817 |
Sensitive |
| ENSG00000253802.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.040252054 |
Sensitive |
| ENSG00000254057.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.036242509 |
Sensitive |
| ENSG00000254142.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.022130637 |
Sensitive |
| ENSG00000254154.4 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.000540394 |
Sensitive |
| ENSG00000254333.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.049422863 |
Sensitive |
| ENSG00000254688.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.033790282 |
Sensitive |
| ENSG00000254733.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.047969111 |
Sensitive |
| ENSG00000254847.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.049556964 |
Sensitive |
| ENSG00000254910.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.008478673 |
Sensitive |
| ENSG00000255090.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.011253237 |
Sensitive |
| ENSG00000255186.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.047148357 |
Sensitive |
| ENSG00000255250.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.004048068 |
Sensitive |
| ENSG00000255320.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.002015684 |
Sensitive |
| ENSG00000255521.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.010706375 |
Sensitive |
| ENSG00000256083.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.048108159 |
Sensitive |
| ENSG00000256268.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.030022943 |
Sensitive |
| ENSG00000256603.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.01500614 |
Sensitive |
| ENSG00000256802.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.007262336 |
Sensitive |
| ENSG00000257038.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.016648538 |
Sensitive |
| ENSG00000257058.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.035219067 |
Sensitive |
| ENSG00000257183.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.013454622 |
Sensitive |
| ENSG00000257732.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.047412695 |
Sensitive |
| ENSG00000257925.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.048662277 |
Sensitive |
| ENSG00000258082.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.004917103 |
Sensitive |
| ENSG00000258181.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.026609127 |
Sensitive |
| ENSG00000258400.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.038885163 |
Sensitive |
| ENSG00000258425.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.017737134 |
Sensitive |
| ENSG00000258457.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.010390274 |
Sensitive |
| ENSG00000258534.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.047842715 |
Sensitive |
| ENSG00000258537.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.001815549 |
Sensitive |
| ENSG00000258860.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.042230547 |
Sensitive |
| ENSG00000258929.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.003386444 |
Sensitive |
| ENSG00000258976.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.009322295 |
Sensitive |
| ENSG00000259065.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.039404319 |
Sensitive |
| ENSG00000259342.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.033588529 |
Sensitive |
| ENSG00000259432.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.034972663 |
Sensitive |
| ENSG00000259473.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.026986386 |
Sensitive |
| ENSG00000259523.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.004248954 |
Sensitive |
| ENSG00000259583.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.037093902 |
Sensitive |
| ENSG00000259604.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.015194975 |
Sensitive |
| ENSG00000259705.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.026712279 |
Sensitive |
| ENSG00000259727.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.028757865 |
Sensitive |
| ENSG00000259883.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.020574543 |
Sensitive |
| ENSG00000260328.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.030413871 |
Sensitive |
| ENSG00000260352.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.016833056 |
Sensitive |
| ENSG00000260507.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.014108962 |
Sensitive |
| ENSG00000260823.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.048129713 |
Sensitive |
| ENSG00000261273.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.040197104 |
Sensitive |
| ENSG00000261392.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.03739631 |
Sensitive |
| ENSG00000261468.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.008808473 |
Sensitive |
| ENSG00000261512.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.014769407 |
Sensitive |
| ENSG00000263745.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.025371058 |
Sensitive |
| ENSG00000264043.2 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.014273972 |
Sensitive |
| ENSG00000264339.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.01480457 |
Sensitive |
| ENSG00000264513.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.029735515 |
Sensitive |
| ENSG00000264635.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.0224514 |
Sensitive |
| ENSG00000265519.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.044355583 |
Sensitive |
| ENSG00000265666.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.009470276 |
Sensitive |
| ENSG00000266088.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.009060943 |
Sensitive |
| ENSG00000266397.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.041697997 |
Sensitive |
| ENSG00000267121.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.047183417 |
Sensitive |
| ENSG00000267123.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.006831274 |
Sensitive |
| ENSG00000267147.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.046446295 |
Sensitive |
| ENSG00000267201.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.019347314 |
Sensitive |
| ENSG00000267375.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.021736523 |
Sensitive |
| ENSG00000267551.3 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.001281703 |
Sensitive |
| ENSG00000267783.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.045409606 |
Sensitive |
| ENSG00000268157.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.042224053 |
Sensitive |
| ENSG00000268186.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.025647615 |
Sensitive |
| ENSG00000269066.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.042877665 |
Sensitive |
| ENSG00000269082.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.04712352 |
Sensitive |
| ENSG00000269895.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.000366193 |
Sensitive |
| ENSG00000270190.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.040048867 |
Sensitive |
| ENSG00000271716.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.041846674 |
Sensitive |
| ENSG00000272070.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.037423206 |
Sensitive |
| ENSG00000272221.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.028354468 |
Sensitive |
| ENSG00000272366.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.01406358 |
Sensitive |
| ENSG00000272457.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.018881318 |
Sensitive |
| ENSG00000272639.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.01448147 |
Sensitive |
| ENSG00000272755.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.017219732 |
Sensitive |
| ENSG00000272789.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.037308601 |
Sensitive |
| ENSG00000272808.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.015370831 |
Sensitive |
| ENSG00000272824.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.015404661 |
Sensitive |
| ENSG00000272861.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.006095818 |
Sensitive |
| ENSG00000273065.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.001705365 |
Sensitive |
| ENSG00000273443.1 |
Doxorubicin (Adriamycin) |
Lung squamous cell carcinoma |
0.043028077 |
Sensitive |
| ENSG00000204758.3 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029625378 |
Sensitive |
| ENSG00000206417.4 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044764592 |
Sensitive |
| ENSG00000224687.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024460319 |
Sensitive |
| ENSG00000226381.3 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000765101 |
Sensitive |
| ENSG00000230606.6 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047387503 |
Sensitive |
| ENSG00000231889.3 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00623697 |
Sensitive |
| ENSG00000237021.2 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016479987 |
Sensitive |
| ENSG00000244586.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000723762 |
Sensitive |
| ENSG00000248774.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046461592 |
Sensitive |
| ENSG00000249584.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03924702 |
Sensitive |
| ENSG00000251414.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025905872 |
Sensitive |
| ENSG00000254144.2 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032118437 |
Sensitive |
| ENSG00000254560.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041768485 |
Sensitive |
| ENSG00000254859.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026617327 |
Sensitive |
| ENSG00000257303.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004622108 |
Sensitive |
| ENSG00000258240.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012873777 |
Sensitive |
| ENSG00000258413.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015076036 |
Sensitive |
| ENSG00000259762.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00664185 |
Sensitive |
| ENSG00000260261.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041569152 |
Sensitive |
| ENSG00000260328.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00636691 |
Sensitive |
| ENSG00000260447.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027903494 |
Sensitive |
| ENSG00000260645.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047521701 |
Sensitive |
| ENSG00000260855.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02214719 |
Sensitive |
| ENSG00000260954.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040538708 |
Sensitive |
| ENSG00000261040.2 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034777186 |
Sensitive |
| ENSG00000261167.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013702543 |
Sensitive |
| ENSG00000261971.2 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024279753 |
Sensitive |
| ENSG00000263624.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026877766 |
Sensitive |
| ENSG00000264290.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04818211 |
Sensitive |
| ENSG00000266278.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04259177 |
Sensitive |
| ENSG00000267543.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007309383 |
Sensitive |
| ENSG00000267745.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001486994 |
Sensitive |
| ENSG00000267924.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005062859 |
Sensitive |
| ENSG00000268543.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0459115 |
Sensitive |
| ENSG00000268912.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030490775 |
Sensitive |
| ENSG00000269397.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040394886 |
Sensitive |
| ENSG00000269910.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026773333 |
Sensitive |
| ENSG00000269940.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043900453 |
Sensitive |
| ENSG00000271755.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039713831 |
Sensitive |
| ENSG00000272308.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013786319 |
Sensitive |
| ENSG00000272327.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026703185 |
Sensitive |
| ENSG00000272657.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018792662 |
Sensitive |
| ENSG00000273295.1 |
Doxorubicin (Adriamycin) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00541259 |
Sensitive |
| ENSG00000157306.10 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.003200707 |
Sensitive |
| ENSG00000179219.5 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.025881188 |
Sensitive |
| ENSG00000203999.4 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.023958938 |
Sensitive |
| ENSG00000206176.5 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.014473609 |
Sensitive |
| ENSG00000206417.4 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.003367968 |
Sensitive |
| ENSG00000211683.3 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.033160836 |
Sensitive |
| ENSG00000215304.3 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.03422387 |
Sensitive |
| ENSG00000223356.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.022153414 |
Sensitive |
| ENSG00000225113.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.034618103 |
Sensitive |
| ENSG00000225439.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.046086504 |
Sensitive |
| ENSG00000225675.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.023413185 |
Sensitive |
| ENSG00000225975.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.013097995 |
Sensitive |
| ENSG00000226380.3 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.020598227 |
Sensitive |
| ENSG00000226419.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.041422557 |
Sensitive |
| ENSG00000226835.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.024792727 |
Sensitive |
| ENSG00000227543.3 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.02367038 |
Sensitive |
| ENSG00000227963.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.045834105 |
Sensitive |
| ENSG00000228109.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.027486092 |
Sensitive |
| ENSG00000228315.7 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.005302294 |
Sensitive |
| ENSG00000228649.4 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.01481799 |
Sensitive |
| ENSG00000228989.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.045645902 |
Sensitive |
| ENSG00000229591.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.004455945 |
Sensitive |
| ENSG00000229839.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.04425735 |
Sensitive |
| ENSG00000230914.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.028830131 |
Sensitive |
| ENSG00000231050.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.015724448 |
Sensitive |
| ENSG00000231249.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.045917355 |
Sensitive |
| ENSG00000231365.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.015762706 |
Sensitive |
| ENSG00000231742.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.018156389 |
Sensitive |
| ENSG00000232445.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.023943551 |
Sensitive |
| ENSG00000232956.4 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.003744639 |
Sensitive |
| ENSG00000233077.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.014829686 |
Sensitive |
| ENSG00000233250.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.015824792 |
Sensitive |
| ENSG00000233611.3 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.042606091 |
Sensitive |
| ENSG00000233937.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.047757928 |
Sensitive |
| ENSG00000234160.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.049241148 |
Sensitive |
| ENSG00000234235.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.002067175 |
Sensitive |
| ENSG00000234753.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.033057947 |
Sensitive |
| ENSG00000234917.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.031106385 |
Sensitive |
| ENSG00000235214.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.023231195 |
Sensitive |
| ENSG00000235954.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.003670977 |
Sensitive |
| ENSG00000236066.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.008622786 |
Sensitive |
| ENSG00000236144.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.023946976 |
Sensitive |
| ENSG00000236558.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.003752607 |
Sensitive |
| ENSG00000237756.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.020158163 |
Sensitive |
| ENSG00000237903.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.03023484 |
Sensitive |
| ENSG00000239608.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.047947923 |
Sensitive |
| ENSG00000241288.3 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.036614922 |
Sensitive |
| ENSG00000241520.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.038918248 |
Sensitive |
| ENSG00000241570.4 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.004345655 |
Sensitive |
| ENSG00000242375.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.025874817 |
Sensitive |
| ENSG00000243069.3 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.028962797 |
Sensitive |
| ENSG00000243960.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.015109723 |
Sensitive |
| ENSG00000247092.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.035687959 |
Sensitive |
| ENSG00000248275.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.002470555 |
Sensitive |
| ENSG00000248367.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.031706854 |
Sensitive |
| ENSG00000248787.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.004441732 |
Sensitive |
| ENSG00000249451.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.010888853 |
Sensitive |
| ENSG00000249595.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.018524406 |
Sensitive |
| ENSG00000249637.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.034596835 |
Sensitive |
| ENSG00000251604.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.042493458 |
Sensitive |
| ENSG00000254353.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.034604996 |
Sensitive |
| ENSG00000254409.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.015388769 |
Sensitive |
| ENSG00000256084.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.044337271 |
Sensitive |
| ENSG00000257264.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.041465533 |
Sensitive |
| ENSG00000258825.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.035732562 |
Sensitive |
| ENSG00000258920.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.012195485 |
Sensitive |
| ENSG00000259623.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.029429935 |
Sensitive |
| ENSG00000259994.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.034879441 |
Sensitive |
| ENSG00000260017.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.009275789 |
Sensitive |
| ENSG00000260060.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.010678059 |
Sensitive |
| ENSG00000260190.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.032186497 |
Sensitive |
| ENSG00000260369.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.033705293 |
Sensitive |
| ENSG00000260708.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.009980093 |
Sensitive |
| ENSG00000260743.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.029740658 |
Sensitive |
| ENSG00000260814.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.006935126 |
Sensitive |
| ENSG00000260927.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.030676554 |
Sensitive |
| ENSG00000260986.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.044898858 |
Sensitive |
| ENSG00000261188.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.025163238 |
Sensitive |
| ENSG00000261280.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.023439005 |
Sensitive |
| ENSG00000261428.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.002406305 |
Sensitive |
| ENSG00000261433.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.012307508 |
Sensitive |
| ENSG00000261589.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.028353821 |
Sensitive |
| ENSG00000261697.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.039966293 |
Sensitive |
| ENSG00000262410.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.010863197 |
Sensitive |
| ENSG00000262837.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.01521042 |
Sensitive |
| ENSG00000263338.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.023197929 |
Sensitive |
| ENSG00000263350.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.029826665 |
Sensitive |
| ENSG00000263470.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.016516742 |
Sensitive |
| ENSG00000263753.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.049333434 |
Sensitive |
| ENSG00000264456.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.030392792 |
Sensitive |
| ENSG00000264577.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.003081662 |
Sensitive |
| ENSG00000264608.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.011483897 |
Sensitive |
| ENSG00000264808.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.005080479 |
Sensitive |
| ENSG00000266402.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.044092844 |
Sensitive |
| ENSG00000266456.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.039338094 |
Sensitive |
| ENSG00000266926.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.013748995 |
Sensitive |
| ENSG00000267080.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.009667593 |
Sensitive |
| ENSG00000267100.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.040495303 |
Sensitive |
| ENSG00000267207.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.002094198 |
Sensitive |
| ENSG00000267321.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.000257316 |
Sensitive |
| ENSG00000267334.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.02741255 |
Sensitive |
| ENSG00000267798.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.006194615 |
Sensitive |
| ENSG00000268015.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.035362061 |
Sensitive |
| ENSG00000268836.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.011973842 |
Sensitive |
| ENSG00000269044.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.020442396 |
Sensitive |
| ENSG00000269235.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.019200095 |
Sensitive |
| ENSG00000269246.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.02065644 |
Sensitive |
| ENSG00000269473.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.037806438 |
Sensitive |
| ENSG00000269600.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.03507907 |
Sensitive |
| ENSG00000269996.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.007523264 |
Sensitive |
| ENSG00000270170.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.042302284 |
Sensitive |
| ENSG00000270760.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.015955779 |
Sensitive |
| ENSG00000271384.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.019569602 |
Sensitive |
| ENSG00000271427.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.031570938 |
Sensitive |
| ENSG00000271782.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.038774858 |
Sensitive |
| ENSG00000271833.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.048278676 |
Sensitive |
| ENSG00000271871.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.023773048 |
Sensitive |
| ENSG00000272077.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.018948729 |
Sensitive |
| ENSG00000272273.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.02852128 |
Sensitive |
| ENSG00000272312.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.047302738 |
Sensitive |
| ENSG00000272365.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.047441205 |
Sensitive |
| ENSG00000272416.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.016557873 |
Sensitive |
| ENSG00000272452.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.022478195 |
Sensitive |
| ENSG00000272462.2 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.039056361 |
Sensitive |
| ENSG00000272699.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.010132641 |
Sensitive |
| ENSG00000272702.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.043165367 |
Sensitive |
| ENSG00000272777.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.049083393 |
Sensitive |
| ENSG00000272787.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.048443679 |
Sensitive |
| ENSG00000272828.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.008126181 |
Sensitive |
| ENSG00000272829.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.002085851 |
Sensitive |
| ENSG00000272856.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.026303636 |
Sensitive |
| ENSG00000272977.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.007182921 |
Sensitive |
| ENSG00000273000.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.007884608 |
Sensitive |
| ENSG00000273186.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.028861797 |
Sensitive |
| ENSG00000273290.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.017440003 |
Sensitive |
| ENSG00000273306.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.028528309 |
Sensitive |
| ENSG00000273335.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.021102677 |
Sensitive |
| ENSG00000273355.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.045982708 |
Sensitive |
| ENSG00000273373.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.004186286 |
Sensitive |
| ENSG00000273375.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.037696966 |
Sensitive |
| ENSG00000273402.1 |
Doxorubicin (Adriamycin) |
Pancreatic adenocarcinoma |
0.039498179 |
Sensitive |
| ENSG00000135253.9 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.017513034 |
Sensitive |
| ENSG00000186056.5 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.015549507 |
Sensitive |
| ENSG00000212163.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.002532569 |
Sensitive |
| ENSG00000212552.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.020173256 |
Sensitive |
| ENSG00000225113.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.033744674 |
Sensitive |
| ENSG00000227637.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.033152929 |
Sensitive |
| ENSG00000228109.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.003317958 |
Sensitive |
| ENSG00000232445.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.046304808 |
Sensitive |
| ENSG00000234084.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.022021748 |
Sensitive |
| ENSG00000235079.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.049691777 |
Sensitive |
| ENSG00000236871.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.025440575 |
Sensitive |
| ENSG00000244558.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.020153076 |
Sensitive |
| ENSG00000248468.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.032195253 |
Sensitive |
| ENSG00000256705.3 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.032809525 |
Sensitive |
| ENSG00000257475.2 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.028207662 |
Sensitive |
| ENSG00000258857.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.028259016 |
Sensitive |
| ENSG00000259187.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.044975925 |
Sensitive |
| ENSG00000259959.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.001847118 |
Sensitive |
| ENSG00000260448.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.017413917 |
Sensitive |
| ENSG00000261159.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.013433082 |
Sensitive |
| ENSG00000261455.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.047380962 |
Sensitive |
| ENSG00000263627.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.013055769 |
Sensitive |
| ENSG00000266579.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.033968939 |
Sensitive |
| ENSG00000267130.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.024709633 |
Sensitive |
| ENSG00000267567.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.03169204 |
Sensitive |
| ENSG00000267667.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.047804583 |
Sensitive |
| ENSG00000267765.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.042510966 |
Sensitive |
| ENSG00000269947.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.043471995 |
Sensitive |
| ENSG00000270084.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.049826476 |
Sensitive |
| ENSG00000272576.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.010802469 |
Sensitive |
| ENSG00000272699.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.019239165 |
Sensitive |
| ENSG00000273186.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.039381743 |
Sensitive |
| ENSG00000273190.1 |
Doxorubicin (Adriamycin) |
Sarcoma |
0.025343897 |
Sensitive |
| ENSG00000181097.5 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.002360954 |
Sensitive |
| ENSG00000184274.3 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.002526741 |
Sensitive |
| ENSG00000184324.11 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.029965269 |
Sensitive |
| ENSG00000197463.8 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.036281056 |
Sensitive |
| ENSG00000203808.6 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.001783332 |
Sensitive |
| ENSG00000203875.6 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.007452189 |
Sensitive |
| ENSG00000204758.3 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.014360232 |
Sensitive |
| ENSG00000215417.6 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.048511827 |
Sensitive |
| ENSG00000215498.4 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.045389384 |
Sensitive |
| ENSG00000215869.3 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.046141047 |
Sensitive |
| ENSG00000223528.3 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.033469296 |
Sensitive |
| ENSG00000223571.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.027318644 |
Sensitive |
| ENSG00000224505.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.047482645 |
Sensitive |
| ENSG00000224635.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.002612876 |
Sensitive |
| ENSG00000224698.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.037914412 |
Sensitive |
| ENSG00000225037.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.022663594 |
Sensitive |
| ENSG00000225778.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.022436654 |
Sensitive |
| ENSG00000225937.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.044933952 |
Sensitive |
| ENSG00000226679.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.045567595 |
Sensitive |
| ENSG00000226699.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.046051034 |
Sensitive |
| ENSG00000227844.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.047608513 |
Sensitive |
| ENSG00000227896.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.016373608 |
Sensitive |
| ENSG00000229036.3 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.017260787 |
Sensitive |
| ENSG00000229852.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.032423593 |
Sensitive |
| ENSG00000230289.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.042601519 |
Sensitive |
| ENSG00000231073.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.024069025 |
Sensitive |
| ENSG00000231966.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.012099929 |
Sensitive |
| ENSG00000232019.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.039359867 |
Sensitive |
| ENSG00000232093.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.045223455 |
Sensitive |
| ENSG00000232490.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.047724637 |
Sensitive |
| ENSG00000232936.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.028961341 |
Sensitive |
| ENSG00000233296.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.009965162 |
Sensitive |
| ENSG00000233515.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.04294768 |
Sensitive |
| ENSG00000234006.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.001772872 |
Sensitive |
| ENSG00000234160.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.028416298 |
Sensitive |
| ENSG00000234171.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.003402711 |
Sensitive |
| ENSG00000234741.3 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.015891511 |
Sensitive |
| ENSG00000234753.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.031655259 |
Sensitive |
| ENSG00000235919.3 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.010044643 |
Sensitive |
| ENSG00000235958.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.01979688 |
Sensitive |
| ENSG00000236617.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.031610694 |
Sensitive |
| ENSG00000236618.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.022534584 |
Sensitive |
| ENSG00000236643.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.033159327 |
Sensitive |
| ENSG00000236751.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.04342975 |
Sensitive |
| ENSG00000236889.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.021570095 |
Sensitive |
| ENSG00000238122.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.036781064 |
Sensitive |
| ENSG00000242125.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.013396496 |
Sensitive |
| ENSG00000242282.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.031272515 |
Sensitive |
| ENSG00000243967.3 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.031805816 |
Sensitive |
| ENSG00000245213.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.045844999 |
Sensitive |
| ENSG00000245768.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.029289007 |
Sensitive |
| ENSG00000247092.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.000818417 |
Sensitive |
| ENSG00000248416.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.013491173 |
Sensitive |
| ENSG00000248884.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.049816204 |
Sensitive |
| ENSG00000249345.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.035249451 |
Sensitive |
| ENSG00000250240.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.034741016 |
Sensitive |
| ENSG00000250988.3 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.002434487 |
Sensitive |
| ENSG00000253125.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.006283904 |
Sensitive |
| ENSG00000253616.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.026816412 |
Sensitive |
| ENSG00000254363.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.026062549 |
Sensitive |
| ENSG00000254812.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.014629883 |
Sensitive |
| ENSG00000255031.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.024417406 |
Sensitive |
| ENSG00000255621.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.046791929 |
Sensitive |
| ENSG00000256427.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.042698838 |
Sensitive |
| ENSG00000257497.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.010433073 |
Sensitive |
| ENSG00000257596.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.017974189 |
Sensitive |
| ENSG00000257808.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.030746196 |
Sensitive |
| ENSG00000258099.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.044414155 |
Sensitive |
| ENSG00000258101.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.017465919 |
Sensitive |
| ENSG00000258303.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.033394276 |
Sensitive |
| ENSG00000258334.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.004335323 |
Sensitive |
| ENSG00000258344.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.02661246 |
Sensitive |
| ENSG00000258920.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.013599853 |
Sensitive |
| ENSG00000259527.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.034417804 |
Sensitive |
| ENSG00000260167.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.033570873 |
Sensitive |
| ENSG00000260196.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.018569825 |
Sensitive |
| ENSG00000260248.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.031195605 |
Sensitive |
| ENSG00000260260.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.000948337 |
Sensitive |
| ENSG00000260515.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.025273512 |
Sensitive |
| ENSG00000260591.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.019624006 |
Sensitive |
| ENSG00000260924.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.01291078 |
Sensitive |
| ENSG00000260938.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.016998393 |
Sensitive |
| ENSG00000261187.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.010045281 |
Sensitive |
| ENSG00000261329.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.049092592 |
Sensitive |
| ENSG00000261840.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.010604077 |
Sensitive |
| ENSG00000263388.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.024039304 |
Sensitive |
| ENSG00000264548.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.012402936 |
Sensitive |
| ENSG00000266401.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.016690282 |
Sensitive |
| ENSG00000266402.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.006908293 |
Sensitive |
| ENSG00000266677.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.029592317 |
Sensitive |
| ENSG00000266983.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.008629222 |
Sensitive |
| ENSG00000267108.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.021551344 |
Sensitive |
| ENSG00000267199.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.014191322 |
Sensitive |
| ENSG00000267480.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.007588769 |
Sensitive |
| ENSG00000267504.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.011581462 |
Sensitive |
| ENSG00000268530.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.047242169 |
Sensitive |
| ENSG00000269893.2 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.029977077 |
Sensitive |
| ENSG00000269947.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.048664264 |
Sensitive |
| ENSG00000270006.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.014832165 |
Sensitive |
| ENSG00000270159.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.013092944 |
Sensitive |
| ENSG00000271782.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.044131428 |
Sensitive |
| ENSG00000271835.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.034717649 |
Sensitive |
| ENSG00000271993.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.004732532 |
Sensitive |
| ENSG00000271998.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.025318294 |
Sensitive |
| ENSG00000272205.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.013372749 |
Sensitive |
| ENSG00000272452.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.000662735 |
Sensitive |
| ENSG00000272524.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.017308914 |
Sensitive |
| ENSG00000272567.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.048302617 |
Sensitive |
| ENSG00000272677.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.001823259 |
Sensitive |
| ENSG00000272983.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.037231087 |
Sensitive |
| ENSG00000273097.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.011146316 |
Sensitive |
| ENSG00000273281.1 |
Doxorubicin (Adriamycin) |
Skin cutaneous melanoma |
0.04123169 |
Sensitive |
